Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma

Clinical trial NCT00005780 · COMPLETED

Trial details

NCT number: NCT00005780
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma Lymphoma, Mantle Cell

Start date: 2000-06-01
Primary completion: 2021-06-09
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.